A Phase Ib Trial of Neoadjuvant Low-Dose Radiation Therapy, Chemotherapy, and Durvalumab for Potentially Resectable Stage III NSCLC

被引：0
|
作者：
Li, J. [1 ]
机构：
[1] Sichuan Prov Canc Hosp, Chengdu, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
stage III nonsmall cell lung cancer; neoadjuvant immunotherapy; low dose radiation therapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P29.07
引用
收藏
页码：S1049 / S1050
页数：2
相关论文
共 50 条
  • [31] Checkmate 77T: A phase III trial of neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) followed by adjuvant nivo in resectable early-stage NSCLC.
    Cascone, Tina
    Provencio, Mariano
    Sepesi, Boris
    Lu, Shun
    Aanur, Nivedita
    Li, Sunney
    Spicer, Jonathan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [32] Patterns of failure in a phase II trial of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) for resectable and borderline resectable (BLR) pancreatic cancer.
    Kharofa, Jordan
    Mierzwa, Michelle Lynn
    Olowokure, Olugbenga Olanrele
    Sussman, Jeffrey J.
    Latif, Tahir
    Gupta, Anumeha
    Esslinger, Hope
    Poreddy, Sampath
    Mcgill, Brian
    Wolf, Eric
    Smith, Milton T.
    Choe, Kyuran Ann
    Ahmad, Syed A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [33] DUART: A phase II study of durvalumab following radiotherapy in patients with unresectable, stage III NSCLC ineligible for chemotherapy
    Filippi, A. R.
    Dziadziuszko, R.
    Garcia Campelo, M. R.
    Paoli, J-B.
    Sawyer, W.
    Perez, I. E. Diaz
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S747 - S747
  • [34] Phase II Trial of Neoadjuvant Tislelizumab with Chemotherapy for Resectable Stage IIB-III Non-small Cell Lung Cancer
    Lin, Y-B
    Long, H.
    Chen, Y-H
    Zhai, W-Y
    Wang, Y-Z
    Rao, B-Y
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S287 - S287
  • [35] Surgical and Clinical Outcomes With Neoadjuvant Atezolizumab in Resectable Stage IB-IIIB NSCLC: LCMC3 Trial Primary Analysis
    Lee, J.
    Chaft, J.
    Nicholas, A.
    Patterson, A.
    Waqar, S.
    Toloza, E.
    Haura, E.
    Raz, D.
    Reckamp, K.
    Merritt, R.
    Owen, D.
    Finley, D.
    Mcnamee, C.
    Blasberg, J.
    Garon, E.
    Mitchell, J.
    Doebele, R.
    Baciewicz, F.
    Nagasaka, M.
    Pass, H.
    Schulze, K.
    Phan, S.
    Johnson, A.
    Bunn, P.
    Johnson, B.
    Kris, M.
    Kwiatkowski, D.
    Wistuba, I.
    Carbone, D.
    Rusch, V.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S59 - S61
  • [36] A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma
    Paiella, Salvatore
    Malleo, Giuseppe
    Simoni, Nicola
    Micera, Renato
    Guariglia, Stefania
    Cavedon, Carlo
    Marchegiani, Giovanni
    Esposito, Alessandro
    Landoni, Luca
    Casetti, Luca
    Tuveri, Massimiliano
    Milella, Michele
    Secchettin, Erica
    Manzini, Gessica
    Bovo, Chiara
    De Pastena, Matteo
    Fontana, Martina
    Salvia, Roberto
    Mazzarotto, Renzo
    Bassi, Claudio
    BMC CANCER, 2021, 21 (01)
  • [37] A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma
    Salvatore Paiella
    Giuseppe Malleo
    Nicola Simoni
    Renato Micera
    Stefania Guariglia
    Carlo Cavedon
    Giovanni Marchegiani
    Alessandro Esposito
    Luca Landoni
    Luca Casetti
    Massimiliano Tuveri
    Michele Milella
    Erica Secchettin
    Gessica Manzini
    Chiara Bovo
    Matteo De Pastena
    Martina Fontana
    Roberto Salvia
    Renzo Mazzarotto
    Claudio Bassi
    BMC Cancer, 21
  • [38] LOW-DOSE NEOADJUVANT EXTERNAL BEAM RADIATION THERAPY FOR SOFT TISSUE SARCOMA
    Devisetty, Kiran
    Kobayashi, Wendy
    Suit, Herman D.
    Goldberg, Saveli I.
    Niemierko, Andrzej
    Chen, Yen-Lin E.
    Raskin, Kevin A.
    Schwab, Joseph H.
    Springfield, Dempsey S.
    Yoon, Sam S.
    Hornicek, Francis J.
    DeLaney, Thomas F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (03): : 779 - 786
  • [39] Phase I trial of short-course chemoradiotherapy followed by chemotherapy as total neoadjuvant therapy for patients with potentially resectable gastric cancer.
    Badgwell, Brian D.
    Das, Prajnan
    Ikoma, Naruhiko
    Murphy, Mariela A. Blum
    Li, Jenny Jing
    Estrella, Jeannelyn
    Minsky, Bruce D.
    Mansfield, Paul F.
    Ajani, Jaffer A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 362 - 362
  • [40] Systemic immune response to a Phase I/II trial of Durvalumab concomitant with neoadjuvant chemotherapy in early stage TNBC
    Blenman, Kim
    Marczyk, Michal
    Foldi, Julia
    Gunasekharan, Vignesh
    Silber, Andrea L. M.
    Pusztai, Lajos
    CANCER RESEARCH, 2023, 83 (05)
12345